Cardinal Health (CAH) Surpasses Q2 Earnings and Revenue Estimates

Core Viewpoint - Cardinal Health reported quarterly earnings of $1.93 per share, exceeding the Zacks Consensus Estimate of$ 1.75 per share, and showing an increase from $1.82 per share a year ago, representing an earnings surprise of 10.29% [1][2] Financial Performance - The company achieved revenues of$ 55.26 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.69%, although this is a decline from $57.45 billion in the same quarter last year [2] - Over the last four quarters, Cardinal has consistently surpassed consensus EPS estimates [2] Stock Performance - Cardinal shares have increased approximately 8% since the beginning of the year, outperforming the S&P 500's gain of 2.7% [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is$ 2.15 on revenues of $54.28 billion, and for the current fiscal year, it is$ 7.84 on revenues of $220.88 billion [7] - The estimate revisions trend for Cardinal is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical - Dental Supplies industry, to which Cardinal belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8]